Prediction of maternal and fetal complications in preeclampsia

Acta Obstetricia et Gynecologica Scandinavica

Volumn 79, Issue 1, 2000, Pages 19-23

  Nisell, Henry ^a   Palm, Kerstin ^a   Wolff, Kerstin ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Complications; Preeclampsia

Indexed keywords

LIVER ENZYME;

ADULT; ARTICLE; BLOOD PH; BLOOD PRESSURE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GESTATIONAL AGE; HEMOLYSIS ELEVATED LIVER LOW PLATELET SYNDROME; HIGH RISK PATIENT; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MATERNAL AGE; NEWBORN INTENSIVE CARE; OLIGURIA; PARITY; PREDICTION; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SMALL FOR DATE INFANT; SYNDROME; THROMBOCYTE COUNT; UMBILICAL CORD BLOOD; URINALYSIS;

ABRUPTIO PLACENTAE; ADULT; FEMALE; FETAL DISEASES; FETAL DISTRESS; FETAL GROWTH RETARDATION; HELLP SYNDROME; HUMANS; INTENSIVE CARE UNITS; OLIGURIA; PRE-ECLAMPSIA; PREGNANCY; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0033986126     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2000.079001019.x     Document Type: Article

References (16)

1. 1. Brown MA, Buddle ML. The importance of nonproteinuric hypertension in pregnancy. Hypertens Pregn 1995; 14: 57-65.
2. 2. Redman C, Beilin L, Bonnar J, Wilkinson R. Plasma-urate measurements in predicting fetal death in hypertensive pregnancy. Lancet 1976; 1: 1370-3.
3. 3. Sagen N, Kjell H, Nilsen S. Serum urate as a predictor of fetal outcome in severe preeclampsia. Acta Obstet Gynecol Scand 1984; 63: 71-5.
4. 4. Lim KH, Friedman SA, Ecker JL, Kao L, Kilpatrick SJ. The clinical utility of serum uric acid measurements in hypertensive diseases of pregnancy. Am J Obstet Gynecol 1998; 178: 1067-71.
5. 5. Spargo BH, Lichtig C, Luger AM, Katz AI, Lindheimer MD. The renal lesion in preeclampsia. In: Lindheimer MD, Katz AI, Zuspan FP, editors. Hypertension in pregnancy. New York: John Wiley & Sons, 1976: pp. 129-37.
6. 6. Tervila L, Goecke C, Timonen S. Estimation of gestosis of pregnancy (EPH-gestosis). Acta Obstet Gynecol Scand 1973; 52: 235-43.
7. 7. Page EW, Christianson E. Influence of blood pressure changes with and without proteinuria upon outcome of pregnancy. Am J Obstet Gynecol 1976; 126: 821-33.
8. 8. Schiff E, Friedman SA, Kao L, Sibai BM. The importance of urinary protein excretion during conservative management of severe preeclampsia. Am J Obstet Gynecol 1996; 175: 1313-16.
9. 9. Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B. Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996; 85: 843-8.
10. 10. Chua S, Redman CW. Prognosis for pre-eclampsia complicated by 5 g or more of proteinuria in 24 hours. Eur J Obstet Gynecol Reprod Biol 1992; 43: 9-12.
11. 11. Boyle JA, Campbell S, Duncan AM, Greig WR, Buchanan WW. Seum uric acid levels in normal pregnancy with observations on the renal excretion of urate in pregnancy. J Clin Pathol 1966; 19: 501-3.
12. 12. Becker BF. Towards the physiological function of uric acid. Free Radic Biol Med 1993; 14: 615-31.
13. 13. Many A, Hubel CA, Roberts JM. Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Am J Obstet Gynecol 1996; 174: 288-91.
14. 14. Abrams BF, Laros RK. Prepregnancy weight, weight gain, and birth weight. Am J Obstet Gynecol 1986; 154: 503-9.
15. 15. Long PA, Abell DA, Beischer NA. Fetal growth retardation and preeclampsia. Br J Obstet Gynaecol 1980; 87: 13-18.
16. 16. Lin CC, Lindheimer MD, River P, Moawad AH. Fetal outcome in hypertensive disorders of pregnancy. Am J Obstet Gynecol 1982; 142: 255-60.